Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: goserelin acetate|DRUG: letrozole|DRUG: anastrozole|DRUG: chemotherapy|PROCEDURE: Surgery
Sponsor: Washington University School of Medicine
Collaborators: National Cancer Institute (NCI)